The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Vollins James since 2019.
This trader's CIK number is 1757833.
At the time of last reporting, Vollins James was the See Remarks of Biodelivery Sciences International Inc. (stock ticker symbol BDSI).
Also see all insider trading activities at Biodelivery Sciences International Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | BDSI | 0 | $0 | 18,541 | $66,747 | 28,413 | $0 |
| 2021 | BDSI | 0 | $0 | 12,136 | $48,907 | 12,136 | $0 |
| 2020 | BDSI | 0 | $0 | 55,324 | $246,287 | 55,324 | $187,691 |
| 2019 | BDSI | 0 | $0 | 29,825 | $181,634 | 29,825 | $103,194 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-02-04 | BDSI | Sale | 18,541 | 3.60 | 66,747 |
| 2022-01-27 | BDSI | Option Ex | 16,276 | .00 | 0 |
| 2022-01-31 | BDSI | Option Ex | 12,137 | .00 | 0 |
| 2021-02-04 | BDSI | Sale | 8,303 | 3.97 | 32,962 |
| 2021-02-08 | BDSI | Sale | 3,833 | 4.16 | 15,945 |
| 2021-02-01 | BDSI | Option Ex | 3,833 | .00 | 0 |
| 2021-01-29 | BDSI | Option Ex | 8,303 | .00 | 0 |
| 2020-12-14 | BDSI | Option Ex | 20,320 | 3.46 | 70,307 |
| 2020-12-14 | BDSI | Sale | 20,320 | 4.46 | 90,627 |
| 2020-12-16 | BDSI | Option Ex | 9,505 | 3.46 | 32,887 |
| 2020-12-16 | BDSI | Sale | 9,505 | 4.48 | 42,582 |
| 2020-05-21 | BDSI | Option Ex | 21,666 | 3.90 | 84,497 |
| 2020-05-21 | BDSI | Sale | 21,666 | 4.60 | 99,663 |
| 2020-03-16 | BDSI | Sale | 3,833 | 3.50 | 13,415 |
| 2020-01-31 | BDSI | Option Ex | 3,833 | .00 | 0 |
| 2019-11-15 | BDSI | Option Ex | 29,825 | 3.46 | 103,194 |
| 2019-11-15 | BDSI | Sale | 29,825 | 6.09 | 181,634 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Vollins James (See Remarks of Biodelivery Sciences International Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.